View up-to-date information on Revolution Medicines Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
19 Jul 2022 | Revolution Medicines Raises USD264.5 in Upsized Public Offering of Shares | Equity Offering | - |
Revolution Medicines Inc |
10 Nov 2021 | Revolution Medicines to Raise USD250 Million in Public Offering of Common Stock | Equity Offering | - |
Revolution Medicines Inc |
04 Mar 2021 | Revolution Medicines Inc Enters Phase I Clinical Trial Agreement with Sarah Cannon Research Institute LLC for RMC-5552 (GDCT0410880) | Contract Service Agreement |
Revolution Medicines Inc
|
Sarah Cannon Research Institute LLC
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer